Literature DB >> 23429463

The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study.

Geoffrey C Nguyen1, Harry Wu, Aliya Gulamhusein, Morgan Rosenberg, Reka Thanabalan, Erik L Yeo, Charles N Bernstein, A Hillary Steinhart, Myles Margolis.   

Abstract

BACKGROUND: Asymptomatic deep vein thrombosis (DVT) occurs in up to 11% of medical inpatients. The incidence of asymptomatic DVT among patients with inflammatory bowel disease (IBD) is unknown but may be even higher. D-dimer is effective for DVT screening, but its utility has not been studied in the IBD population.
METHODS: Hospitalized and ambulatory patients with IBD during flares were recruited between 2009 and 2011. Those with clinical symptoms of venous thromboembolism or previous venous thromboembolism were excluded. We determined the prevalence of DVT among asymptomatic subjects using lower extremity Doppler ultrasound and assessed the performance characteristics of the D-dimer in this high-risk study population.
RESULTS: We enrolled 101 hospitalized and 49 ambulatory patients with IBD during active flares. There were no cases of proximal DVT detected by lower extremity Doppler ultrasound. The 95% confidence interval (CI) for the rate of proximal DVT was 0% to 2%. D-dimer was elevated in 60% of subjects without DVT, occurring more frequently among hospitalized than ambulatory subjects [89% versus 65%, P = 0.01; adjusted odds ratio (aOR), 4.16, 95% CI, 1.58-10.9]. Other predictors of elevated D-dimer were incremental decade in age (aOR, 1.97; 95% CI, 1.24-3.14); ulcerative colitis versus Crohn's disease diagnosis (aOR, 3.38; 95% CI, 1.29-8.84); and every 10-unit increase in C-reactive protein (aOR, 1.33; 95% CI, 1.09-1.62).
CONCLUSION: From this pilot study, there appears to be low prevalence of asymptomatic DVTs among patients with IBD during flares. The high prevalence of elevated D-dimer in DVT-negative patients limits its utility in IBD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429463     DOI: 10.1097/MIB.0b013e3182802a65

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.

Authors:  Gilaad G Kaplan; Allen Lim; Cynthia H Seow; Gordon W Moran; Subrata Ghosh; Yvette Leung; Jennifer Debruyn; Geoffrey C Nguyen; James Hubbard; Remo Panaccione
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

2.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Elizabeth Scoville; Gauree G Konijeti; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

Review 3.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Coagulation parameters in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Aliye Soylu; Tulin Kendir; Ali Tuzun Ince; Hatice Dolapcioglu; Sevim Purisa; Cengiz Bolukbas; Haci Mehmet Sokmen; Remzi Dalay; Oya Ovunc
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 5.  Colitis-associated colon cancer: Is it in your genes?

Authors:  Lauren Van Der Kraak; Philippe Gros; Nicole Beauchemin
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

6.  D-Dimer levels are correlated with disease activity in Crohn's patients.

Authors:  Junwu Zhang; Zhen Guo; Wei Yang; Zhongliang Zhu; Wanzhong Kong; Sujie Zheng; Lei Jiang; Xianming Fei; Yanxia Chen; Jinlin Liu
Journal:  Oncotarget       Date:  2017-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.